Daily profile and variability of blood pressure in patients with arterial hypertension (AH) in combination with COPD.

V. A. Potabashniy, V. I. Fesenko, T. Z. Burtniak

Abstract


To date, despite the improved approach to managing patients with AH, control of blood pressure remains unsatisfactory in some categories of patients. This problem is particularly topical in AH combined with COPD depending on the peculiarities of the course and difficulty in their diagnosis. Thanks  to the use of 24-hour monitoring method, it is possible to objectify the true blood pressure profile during the day and diagnose AH at a qualitatively new level. In patients with a combination of AH and COPD, there are certain features of the clinical course that can be determined with the use of 24-hour BP monitoring. A direct relationship between the profile of blood pressure, the clinical groups of COPD, as well as the time of its onset regarding hypertension was revealed.


Keywords


arterial hypertension; chronic obstructive pulmonary desease; daily blood pressure profile

References


Dolhusheva Yu.A. [β-agonists of different dura­tion of action in patients with combination of cardio­vascular pathology and broncho-obstructive illnesses]. Prakt. pulmonolohyia. 2015;2:41-47. Russian.

Kovalenko VM, Kornatskyi VM. [Problems of health and life expectancy in modern conditions]. Po­sibnyk. 2017;24-28. Ukrainian.

MukharliamovNM, Satbekov ZhS, Suchkov VV. [Systemic arterial hypertension in patients with chronic obstructive pulmonary disease]. Kardiologiya. 1974;12:55-58. Russian.

[Order of the Ministry of Health ofUkrainedated May 24, 2012 No. 384 "On Approval and Implementation of Medical-Technological Documents for the Stan­dardization of Medical Assistance in Arterial Hyper­tension"]. Kyiv; 2012. Ukrainian.

[Order of the Ministry of Health ofUkrainedated June 27, 2013 № 555 "On Approval and Implementation of Medical-Technological Documents for the Standardization of Medical Assistance in Chronic Ob­structive Pulmonary Disease"]. Kyiv; 2013. Ukrainian.

Chandy Dipak, Aronow S Wilbert, Banach Ma­ciej. Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease. Integrated Blood Pressure Control. 2013;6:101-9.

ESH/ESC Guidelines For The Management Of Arterial Hypertension; 2013.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, ma­nagement and prevention of chronic obstructive pul­mo­nary disease. Medical Communications Resources; 2017.

Marie Fisk,CarmelM. McEniery, Nichola Gale. Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease. A Large Case-Controlled Study. Hypertension. 2018;71:499-506.


GOST Style Citations


  1. Долгушева Ю.А. β-агонисты различной дли­тельности действия у пациентов с сочетанием сер­дечно-сосудистой патологии и бронхообструктивных заболеваний / Ю.А. Долгушева, К.А. Зыков, И.Е. Ча­зова // Практ.пульмонология. – 2015. – № 2. – С. 41-47.
  2. Коваленко В.М. Проблеми здоров’я  і трива­лості життя в сучасних умовах: посібник / В.М. Кова­ленко, В.М. Корнацький. – Київ, 2017. – 24-28.
  3. Мухарлямов Н.М. Системная артериальная ги­пертензия у больных с хроническими обструктив­ными заболеваниями легких / Н.М. Мухарлямов, Ж.С. Сат­беков, В.В. Сучков // Кардиология. – 1974. – № 12. – С. 55-58.
  4. Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при артеріальній гіпертензії: Наказ МОЗ України від 24.05.2012 № 384.
  5. Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при хронічному обструктивному захворю­ванні легень: Наказ МОЗ України від 27.06.2013 № 555.
  6. Chandy Dipak. Current perspectives on treatment of hypertensive patients with chronic obstructive pul­monary disease / Dipak Chandy, Wilbert S. Aronow, Ma­ciej Banach // Integrated Blood Pressure Control. – 2013. –N 6. – P. 101-109. 
  7. ESH/ESC Guidelines For The Management Of Arterial Hypertension. – 2013.
  8.  Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, mana­gement and prevention of chronic obstructive pulmonary disease // Medical Communications Resources. – 2017.
  9. Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease. A Large Case-Controlled Study / Fisk Marie, McEniery Carmel M., Gale Nichola // Hypertension. – 2018. – 71. – 499-506.




DOI: https://doi.org/10.26641/2307-0404.2018.2(part1).129515

Refbacks

  • There are currently no refbacks.